Why the study?
Concentrations of different circulating microparticles may have clinical and physiological relevance to cardiovascular disease pathologies.
Do plasma concentrations of specific microparticles differ between healthy older men and those with CAD or NSTEMI?
Population
CAD patients (n = 10), NSTEMI patients (n = 13), and healthy older men (n = 15) 60-75 years old
Comparison
CAD vs NSTEMI vs healthy older controls
Design
Cross-sectional comparative study
Authors
Loading...
Differential MP levels across CAD stages; hypothesis-generating for biomarker potential, larger prospective studies needed.
Do plasma concentrations of specific microparticles differ between healthy older men and those with CAD or NSTEMI?
CD31+/CD42b- microparticles are significantly lower in patients with CAD and NSTEMI compared to healthy individuals, suggesting potential utility as a cardiovascular biomarker.
Landers‐Ramos et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: